Top

BY Devon Carter

Can immunotherapy treat breast cancer? For certain patients, the answer is yes.

Two immunotherapy drugs — atezolizumab and pembrolizumab — are approved by the Food and Drug Administration (FDA) for patients with metastatic triple-negative breast cancer. Both of these are immune checkpoint inhibitors, the most common type of immunotherapy.

To understand how these drugs work, which breast cancer patients are benefiting and...

Image: Immunotherapy treating breast cancer

BY Cynthia DeMarco

Studies show that wearing a mask properly and consistently practicing good social distancing can significantly reduce the spread of the coronavirus...

BY Clayton Boldt, Ph.D.

In the last decade, immunotherapy has become a viable treatment option for many cancer patients. Unlike radiation and chemotherapy, immunotherapy...

BY Ciara Toth

When the coronavirus (COVID-19) pandemic reached Houston earlier this year, I was already expecting it to affect my leukemia treatment schedule. I knew my doctors would probably want to limit my in-person clinic visits, and maybe even conduct some of my check-ups virtually.

What I didn’t expect was the way the pandemic would affect my attitude about my end-of-treatment celebration plans. And that that shift,...

Ciara Toth's art project

BY Molly Adams

Mantle cell lymphoma was classified as a separate type of non-Hodgkin lymphoma in 1992. Since then, it’s historically been one of the most...

BY Cynthia DeMarco

Self-diagnosis has never been an exact science. But with the coronavirus (COVID-19) now added to the mix, figuring out what those sniffles...

BY Heather Alexander

Your risk for cancer is linked to many factors, and some people are at greater risk than others.

Certain ethnic groups and people with...

BY Cynthia DeMarco

Fall is here, and that’s got many people thinking about Halloween and other autumn activities. But as the coronavirus (COVID-19) pandemic...

BY Ronda Wendler

Growing up in El Paso, Jon Filbert loved collecting autographed Major League Baseball trading cards.

“I really was into it, and I still...

BY Clayton Boldt, Ph.D.

Medullary thyroid cancer is a rare cancer diagnosed in about 1,200 patients annually in the U.S. Because it’s often a silent disease, many...

BY Debbie Logan

I have suffered from migraines for 30 years. And to cope with the pain, I enjoy journaling. It helps me to distract myself and find clarity...

BY Clayton Boldt, Ph.D.

Studying new cancer therapies through clinical trials is essential for progress in cancer care. Phase I clinical trials are designed to evaluate...

BY Molly Adams

Now that we’re several months into the COVID-19 pandemic, many of us are feeling the emotional toll of the uncertainty, worry and dramatic...

BY Emily Aldrich

When I learned six years ago that I carry a genetic mutation called CDH1, my initial response was anger. I had just gotten married, and my...

BY Ronda Wendler

Since childhood, Birdia Churchwell has been fascinated by science.

“I was interested in the why, so I spent my time reading, asking...

BY Nicole Love

When I was diagnosed with breast cancer at MD Anderson in January 2019, my biggest concern wasn’t actually my breasts. It was my heart. Because...

BY Clayton Boldt, Ph.D.

In cancer, there are often large-scale deletions, rearrangements or other disruptions to our genetic information, which lead to a phenomenon...

BY Meagan Raeke

Your body is home to trillions of microbes. These bacteria, viruses, fungi and other organisms impact everything from how you process food...

BY Lainie Jones

I’ve been coming to MD Anderson for almost 11 years now, because I have a rare genetic condition called Li-Fraumeni Syndrome. It puts me at...

BY Molly Adams

When you’re undergoing cancer treatment, it’s important to get the right care at the right time – especially when it comes to seeking emergency...

BY David Dudak

When I got my second cancer diagnosis in early 2017, I was already going to MD Anderson regularly to see Dr. Alessandra Ferrajoli. I’d been...

BY Emily Aldrich

In 2014, I learned that I carry a genetic mutation called CDH1, which markedly increases my risk of developing breast and stomach cancers....

BY Meagan Raeke

For patients with non-small cell lung cancer (NSCLC) with EGFR mutations, targeted therapy with EGFR tyrosine kinase inhibitors (TKIs) has...

BY Danielle Underferth

If you’re due for a mammogram, it’s important that you choose the facility wisely.

Getting the most accurate mammogram results possible...

BY Andrew Joseph Pegoda, Ph.D.

As a neurofibromatosis survivor, I’m already in a high-risk group for contracting the coronavirus (COVID-19). So, even though I’ve never had...